PHARMACOKINETICS OF METHIMAZOLE AFTER ORAL-ADMINISTRATION OF CARBIMAZOLE AND METHIMAZOLE, IN HYPER-THYROID PATIENTS

被引：59

作者：

SKELLERN, GG

KNIGHT, BI

LOW, CKL

ALEXANDER, WD

MCLARTY, DG

KALK, WJ

机构：

[1] UNIV GLASGOW,WESTERN INFIRM,GARDINER INST,DEPT MED,GLASGOW G11 6NT,SCOTLAND

[2] UNIV GLASGOW,STOBHILL GEN HOSP,DEPT MATERIA MED,GLASGOW G21 3UW,GLASGOW,SCOTLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1980年 / 9卷 / 02期

关键词：

D O I：

10.1111/j.1365-2125.1980.tb05823.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：137 / 143

页数：7

共 22 条

[1] METABOLISM OF 35S-LABELLED ANTITHYROID DRUGS IN MAN [J].

ALEXANDER, WD ;

EVANS, V ;

MACAULAY, A ;

GALLAGHER, TF ;

LONDONO, J .

BMJ-BRITISH MEDICAL JOURNAL, 1969, 2 (5652) :290-+

[2] MEASUREMENT OF METHIMAZOLE IN HUMAN-PLASMA USING GAS-LIQUID-CHROMATOGRAPHY [J].

BENDING, MR ;

STEVENSON, D .

JOURNAL OF CHROMATOGRAPHY, 1978, 154 (02) :267-271

[3]

CROOKS J, 1973, BRIT J PHARMACOL, V49, pP156

[4] SERUM LEVEL APPROACH TO INDIVIDUALIZATION OF DRUG DOSAGE [J].

KOCHWESER, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (01) :1-8

[5]

LOW LCK, 1979, LANCET, V1, P493

[6] ANTI-THYROID DRUGS [J].

MARCHANT, B ;

LEES, JFH ;

ALEXANDER, WD .

PHARMACOLOGY & THERAPEUTICS PART B-GENERAL & SYSTEMATIC PHARMACOLOGY, 1978, 3 (03) :305-348

[7] ACCUMULATION OF S-35-ANTITHYROID DRUGS BY THYROID-GLAND [J].

MARCHANT, B ;

LAZARUS, JH ;

ALEXANDER, WD ;

CLARK, DH ;

LEES, J .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1972, 34 (05) :847-+

[8]

MCNEE C, 1973, SCOT MED J, V18, P67

[9]

MELANDER A, 1978, 9TH ANN M EUR THYR A

[10]

METZLER CM, 1969, NONLIN COMPUTOR PROG

← 1 2 3 →